Filing Details

Accession Number:
0001453687-24-000104
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-14 16:41:54
Reporting Period:
2024-08-12
Accepted Time:
2024-08-14 16:41:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1453687 Cartesian Therapeutics Inc. RNAC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1237409 C Timothy Barabe C/O Cartesian Therapeutics, Inc.
704 Quince Orchard Road
Gaithersburg MD 20878
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-12 7,500 $12.70 21,766 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $19.66 2034-01-01 7,600 7,600 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2034-01-01 7,600 7,600 Direct
Footnotes
  1. On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.
  2. This award will vest in 36 equal monthly installments, so that it shall be fully vested on the third anniversary of the date of grant.